A History of Outperforming Analyst Forecasts and Beating the Odds: Celestica, Inc (CLS)

With 7.21 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.97 million shares. The 52-week range on CLS shows that it touched its highest point at $144.27 and its lowest point at $40.25 during that stretch. It currently has a 1-year price target of $144.83. Beta for the stock currently stands at 2.04.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CLS was down-trending over the past week, with a drop of -14.98%, but this was down by -26.93% over a month. Three-month performance surged to 8.49% while six-month performance rose 78.41%. The stock gained 112.13% in the past year, while it has lost -2.25% so far this year. A look at the trailing 12-month EPS for CLS yields 3.75 with Next year EPS estimates of 5.84. For the next quarter, that number is 1.11. This implies an EPS growth rate of 24.26% for this year and 21.18% for next year. EPS is expected to grow by 22.05% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 46.52%.

Float and Shares Shorts:

At present, 116.36 million CLS shares are outstanding with a float of 115.77 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CLS since 9 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $3.96354 being high and $3.68921 being low. For CLS, this leads to a yearly average estimate of $3.8126. Based on analyst estimates, the high estimate for the next quarter is $1.18 and the low estimate is $1.13. The average estimate for the next quarter is thus $1.16.